The finding that Ko143 was only able to enhance PpIX fluorescence and ALA-PDT response in two TNBC cell lines with increased ABCG2 transporter activity, but not in normal and other cancer cell lines without elevated ABCG2 activity, demonstrates the selectivity of this therapeutic enhancement. Here, ABCG2 is linked to cancer.